GH Research to Present at Cantor Global Healthcare Conference
Ticker: GHRS · Form: 6-K · Filed: Sep 16, 2024 · CIK: 1855129
Sentiment: neutral
Topics: conference-participation, investor-relations
TL;DR
GH Research is hitting the Cantor Healthcare conference Sept 17-19 in NYC for investor chats.
AI Summary
GH Research PLC announced its participation in the Cantor Global Healthcare Conference, scheduled for September 17-19, 2024, in New York. The company will engage in a fireside chat and conduct one-on-one investor meetings during the event.
Why It Matters
This conference provides GH Research an opportunity to engage with investors and potentially highlight its pipeline and strategic initiatives, which could influence its stock valuation.
Risk Assessment
Risk Level: low — This filing is a routine announcement of participation in a conference, with no material financial or operational changes disclosed.
Key Players & Entities
- GH Research PLC (company) — Registrant
- Cantor Global Healthcare Conference (company) — Event
- September 17-19, 2024 (date) — Conference dates
- New York (location) — Conference location
FAQ
What is the purpose of GH Research PLC's participation in the Cantor Global Healthcare Conference?
GH Research PLC will participate in a fireside chat and hold one-on-one investor meetings during the conference.
When and where is the Cantor Global Healthcare Conference taking place?
The conference is scheduled to take place from September 17-19, 2024, in New York.
What type of report is this filing?
This filing is a Form 6-K, Report of Foreign Private Issuer.
What is GH Research PLC's primary business sector?
GH Research PLC is in the Pharmaceutical Preparations sector (SIC code 2834).
What is the filing date of this report?
The filing date is September 16, 2024.
Filing Stats: 175 words · 1 min read · ~1 pages · Grade level 14.9 · Accepted 2024-09-16 17:00:12
Filing Documents
- ef20035922_6k.htm (6-K) — 7KB
- 0001140361-24-041184.txt ( ) — 8KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2024. Commission File Number: 001-40530 GH Research PLC (Exact name of registrant as specified in its charter) Joshua Dawson House Dawson Street Dublin 2 D02 RY95 Ireland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F GH Research PLC will participate in a fireside chat and hold one-on-one investor meetings during the Cantor Global Healthcare Conference, which is scheduled to take place from September 17-19, 2024 in New York. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GH Research PLC Date: September 16, 2024 By: /s/ Julie Ryan Name: Julie Ryan Title: Vice President, Finance 2